New combo pill for heart failure put to the test in healthy volunteers
NCT ID NCT07015671
First seen Nov 03, 2025 · Last updated May 24, 2026 · Updated 29 times
Summary
This study looked at how a new tablet combining two heart failure medicines (torsemide and spironolactone) is absorbed by the body. Twenty-four healthy adults took single doses of the combo pill, each drug alone, or both drugs together. The goal was to see if the combo works the same as taking the drugs separately. This helps doctors design better treatments for heart failure patients.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BIOEQUIVALENCE STUDY IN HEALTHY SUBJECTS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Sarfez Pharmaceuticals
Vienna, Virginia, 22182, United States
Conditions
Explore the condition pages connected to this study.